Your browser doesn't support javascript.
loading
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
Shin, Ji Eun; Kim, Soo-Hyun; Kong, Mingyu; Kim, Hwa-Ryeon; Yoon, Sungmin; Kee, Kyung-Mi; Kim, Jung Ah; Kim, Dong Hyeon; Park, So Yeon; Park, Jae Hyung; Kim, Hongtae; No, Kyoung Tai; Lee, Han-Woong; Gee, Heon Yung; Hong, Seunghee; Guan, Kun-Liang; Roe, Jae-Seok; Lee, Hyunbeom; Kim, Dong-Wook; Park, Hyun Woo.
Afiliação
  • Shin JE; Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Kim SH; Leukemia Omics Research Institute, Eulji University, Uijeongbu-si, Gyeonggi-Do, Republic of Korea.
  • Kong M; Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology, Seoul, 02792, Korea.
  • Kim HR; Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Yoon S; Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Kee KM; Leukemia Omics Research Institute, Eulji University, Uijeongbu-si, Gyeonggi-Do, Republic of Korea.
  • Kim JA; Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
  • Kim DH; Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Park SY; Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Park JH; Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Kim H; School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea.
  • No KT; Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Lee HW; Bioinformatics and Molecular Design Research Center (BMDRC), Incheon, 21983, Korea.
  • Gee HY; Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Hong S; Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
  • Guan KL; Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Roe JS; Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093, USA.
  • Lee H; Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Kim DW; Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology, Seoul, 02792, Korea.
  • Park HW; Leukemia Omics Research Institute, Eulji University, Uijeongbu-si, Gyeonggi-Do, Republic of Korea. dwkim@eulji.ac.kr.
Mol Cancer ; 22(1): 177, 2023 11 06.
Article em En | MEDLINE | ID: mdl-37932786
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Crise Blástica Limite: Animals / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Crise Blástica Limite: Animals / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de publicação: Reino Unido